Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-08-25 00:00:00 ET · period of report 2025-08-22 · accession 0001946439-25-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-25 | 2025-08-22 | ANIP | Davis Krista | SVP, Chief HR Off | S - Sale | $91.10 | -1,763 | 62.9K | -3% | -$160.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-22 | S | D | 1,763 | $91.10 | 62,896 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $91.01 to $91.19. The price reported above reflects the weighted average sales price. |